Triple elimination screening for pregnancy: study at Dokter Soekardjo Hospital

Abstract

Triple Elimination is an initiative that supports the eradication of mother-to-child transmission of three infectious diseases: HIV, syphilis, and hepatitis B. Common tests for this initiative include anti-HIV, RPR-TP, and HBsAg rapid screenings. This descriptive study aimed to determine the results of these screenings in pregnant women at Dokter Soekardjo Hospital. We used a total sampling method to include a total of 182 pregnant women who met the inclusion criteria. The findings revealed that the majority of pregnant women were in early adulthood (26-35 years) and late adulthood (36-45 years), each comprising 32.96%. Most subjects were housewives (84.61%) who had a senior high school education (38.46%) , and were examined during their third trimester (58.80%). The RPR-TP rapid screening showed reactive results in 7 women (3.84%). No reactive results were found for Anti-HIV, while one woman (0.54%) tested reactive for HBsAg. The third trimester detected the most reactive results, with 6 women showing reactivity: 5 (4.675%) for RPR-TP and 1 (0.93%) for HBsAg. Despite the absence of reactive Anti-HIV results, precautions against HIV transmission during pregnancy are crucial due to the risk of placental infection or damage. The study's RPR-TP results highlight the importance of addressing reactive cases, given their potential impact. Additionally, performing HBsAg tests remains critical due to the risk of chronic HBV infection in babies.